Showing 1621-1630 of 8667 results for "".
SCALE Notes
https://practicaldermatology.com/issues/supplements/scale-notes/22088/News and views from Music City SCALEAdjusting to a Paradigm Shift in Documentation
https://practicaldermatology.com/topics/practice-management/adjusting-to-a-paradigm-shift-in-documentation/21681/Clinicians can navigate changing rules by selecting technologies that accommodate rapid shifts in documentation.PRP: Assessing Its Safety and Efficacy
https://practicaldermatology.com/topics/practice-management/prp-assessing-its-safety-and-efficacy/20580/As use of platelet-rich plasma grows in popularity, a dermatologist undertakes a review of the current evidence.Update: Biomarkers for Guiding Treatment in Early Stage Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-biomarkers-for-guiding-treatment-in-early-stage-melanoma/23260/A look at current tools for risk stratification of melanoma, controversy surrounding SLNB for staging, and novel adjuvant immunotherapies for early stage disease.DermWireTV: Zoryve Approved; New SDPA President; Project Determi-Nation; Stelara for Pediatric PsA
https://practicaldermatology.com/topics/psoriasis/dermwiretv-zoryve-approved-new-sdpa-president-project-determi-nation-stelara-for-pediatric-psa/20115/FDA has approved Zoryve from Arcutis Biotherapeutics for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. The novel formulation of roflumilast cream 0.3% is indicated for once-daily application. Stelara (ustekinumab) from Janssen is now approveEffectively Manage Older Patients with Skin Diseases
https://practicaldermatology.com/topics/psoriasis/effectively-manage-older-patients-with-skin-diseases/21749/As the population ages, staying abreast of the latest developments in geriatric dermatology is critical.Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in aLidocaine Shortage: Perspectives, Alternatives, and Pathways Forward
https://practicaldermatology.com/topics/practice-management/lidocaine-shortage-perspectives-alternatives-and-pathways-forward/23949/Supply chain issues, communication barriers, and regulatory inconsistencies cause problems for practitioners and patients.Prescribing Pitfalls Part II: Techniques for Prescribing Success
https://practicaldermatology.com/topics/practice-management/prescribing-pitfalls-part-ii-techniques-for-prescribing-success/21413/Simple strategies employed in the office can improve the likelihood of treatment success and enhance patient satisfaction.A Practical Primer for Dysport, Part 1: Speaking the Language and Strategies for Success with the Glabella and Forehead
https://practicaldermatology.com/topics/general-topics/PD0709_09-php/22804/To gain the most benefit from the newest botulinum neurotoxin, clinicians need to think about the product in its own terms.